Stocks · News reference
Financial firm Equita has added DiaSorin to its small-cap portfolio and upgraded the stock to a 'buy' rating ahead of the company's upcoming quarterly results.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Trump mandates AI data centers produce their own electricity, as BlackRock's Larry Fink warns construction delays could trigger inflation.
Will the S&P 500 open higher? Polymarket odds hit 68% as Wall Street eyes Meta and Tesla earnings, booming AI demand, and $110 Brent crude.
Health care stocks climbed to record highs by midday Tuesday, with defensives and small caps leading a recovery from an early dip.